首页|期刊导航|广东医学|继发性骨质疏松症的诊治困境及其进展

继发性骨质疏松症的诊治困境及其进展OA

Secondary osteoporosis:current status,clinical dilemmas,and research advances

中文摘要英文摘要

继发性骨质疏松症(SOP)病因复杂,可由多系统疾病引起.当前,在干预SOP时,易面临识别困难、指南缺乏的困境,是值得重视的一大公共卫生问题.本文系统梳理了呼吸、消化、风湿、内分泌、循环、血液、肾脏系统疾病与SOP的发病机制与诊疗现状及进展,并对各系统疾病合并SOP的诊疗特点进行述评.研究认为,SOP的防治亟需从"单病诊疗"向"共病管理"转变,应推动各专科建立骨骼健康意识与制定指南,整合低成本的综合干预策略,并构建多学科协作路径,以实现原发病控制与骨骼健康的双重获益.

Secondary osteoporosis(SOP)is a complex metabolic bone disorder caused by a wide range of system-ic diseases.At present,the prevention and management of SOP remain challenging because of difficulties in early identifi-cation and the lack of comprehensive clinical guidelines,making SOP an important public health concern that deserves greater attention.This review systematically summarizes the pathogenesis,current diagnostic and therapeutic status,and recent advances in SOP associated with diseases of the respiratory,digestive,rheumatologic,endocrine,cardiovascular,hematologic,and renal systems.In addition,the diagnostic and therapeutic characteristics of SOP secondary to different systemic diseases are critically discussed.Current evidence suggests that the prevention and treatment of SOP urgently re-quire a transition from a"single-disease management"model to a"multimorbidity management"approach.It is essential to promote awareness of skeletal health among different medical specialties,establish disease-specific clinical guidelines,integrate cost-effective comprehensive intervention strategies,and develop multidisciplinary collaborative pathways to a-chieve dual benefits in controlling primary diseases and preserving bone health.

李佳;郑柯宏

中国人民解放军南部战区总医院内分泌科(广东 广州 510010)广东药科大学(广东 广州 510006)

医药卫生

继发性骨质疏松症困境骨密度骨骼健康诊疗

secondary osteoporosisdilemmasbone mineral densitybone healthdiagnosis and treatment

《广东医学》 2026 (7)

961-972,12

国家重点研发计划项目(2021YFC2501701)

10.13820/j.cnki.gdyx.20261283

评论